SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
Luna E, Ruiz S, Garinot M, Chavagnac C, Agrawal P, Escobar J, Revet L, Asensio MJ, Piras F, Fang FG, Drake DR 3rd, Rokbi B, Larocque D, Haensler J.
Luna E, et al.
NPJ Vaccines. 2024 Dec 19;9(1):253. doi: 10.1038/s41541-024-01046-0.
NPJ Vaccines. 2024.
PMID: 39702373
Free PMC article.